View Pricing

List Price

$85.00

APA Members

$68.00

20% off

APA Resident-Fellow Members

$63.75

25% off

Buying In Canada or Europe?

Add To Cart

The Early Stages of Schizophrenia

Edited by Robert B. Zipursky, M.D., and S. Charles Schulz, M.D.

  • ISBN 978-0-88048-840-2
  • Item #8840

Description

In sharp contrast to the prevailing belief during the past century that schizophrenia inevitably results in a progressive deteriorating clinical course, research since the early 1980s shows that early intervention can significantly improve the long-term outcome of this complex illness. With very early treatment, many affected individuals can achieve an excellent recovery.

This research has set off an explosion of interest in—and optimism about—early intervention in what was once thought to be an intractable illness. The work of 19 top experts in the field of schizophrenia research is available in this single, powerful volume that introduces the concept of early intervention and describes the clinical approaches most likely to facilitate the fullest degree of recovery. Contributors review the clinical and epidemiological evidence that supports the importance of comprehensive and optimal treatment during the early stages of schizophrenia—treatment that must encompass emotional, family, and vocational as well as pharmacological needs of affected individuals.

This rich overview is organized into three major parts:

  • Early Intervention, Epidemiology, and Natural History of Schizophrenia, which presents an overview of important concepts in early intervention and reviews our current understanding of the outcome from a first episode of schizophrenia, including which features predict the onset of first-episode psychosis
  • Management of the Early Stages of Schizophrenia, which reviews the critical management issues in providing specialized and optimal care to this complex patient group and their families, including meeting the patient’s emotional needs
  • Neurobiological Investigations of the Early Stages of Schizophrenia, which describes important specialized topics that contribute to our understanding of the first episode of schizophrenia, including schizophrenia in childhood and adolescence and cognitive dysfunction in the early stages of schizophrenia

This ground-breaking volume provides reason for new optimism about the treatment and outcome of schizophrenia. With its dramatically different perspective on the potential long-term outcome of a still-baffling illness, this volume is a must-read for mental health practitioners and educators, psychiatry residents, and family members of affected individuals.

Contents

Contributors
Introduction
PART I: Early Intervention, Epidemiology, and Natural History of Schizophrenia
Chapter 1. “Closing In”: What Features Predict the Onset of First-Episode Psychosis Within an Ultra-High-Risk Group?
Chapter 2. Epidemiology of First-Episode Schizophrenia: The Suffolk County Mental Health Project
Chapter 3. Investigating the Early Stages of Schizophrenia: The Hillside Prospective Study of First-Episode Schizophrenia
PART II: Management of the Early Stages of Schizophrenia
Chapter 4. Optimal Pharmacologic Management of the First Episode of Schizophrenia
Chapter 5. Meeting the Patient’s Emotional Needs
Chapter 6. Family Intervention in the Early Stages of Schizophrenia
PART III: Neurobiological Investigations of the Early Stages of Schizophrenia
Chapter 7. Childhood-Onset Schizophrenia: Research Update
Chapter 8. Schizophrenia During Adolescence
Chapter 9. Cognitive Impairment in Early-Stage Schizophrenia
Afterword
Index

Contributors

Evelyn J. Bromet, Ph.D.
April A. Collins, M.S.W.
Marilyn A. Davies, Ph.D.
Shmuel Fennig, M.D.
Robert L. Findling, M.D.
Lee Friedman, Ph.D.
John T. Kenny, Ph.D.
Sanjiv Kumra, M.D.
Jeffrey A. Lieberman, M.D.
Elizabeth McCay, R.N., Ph.D.
Patrick D. McGorry, M.D., Ph.D.
Ramin Mojtabai, M.D., Ph.D.
Robert Nicolson, M.D.
Lisa J. Phillips, B.Sc., M.Psych.
Judith L. Rapoport, M.D.
Kathryn Ryan, R.N., M.Sc.(N.)
S. Charles Schultz, M.D.
Alison R. Yung, M.B., M.P.M.
Robert B. Zipursky, M.D.

About the Authors

Robert B. Zipursky, M.D., is the Tapscott Chair in Schizophrenia Studies at the University of Toronto and the Clinical Director of the Schizophrenia and Continuing Care Program at the Centre for Addiction and Mental Health in Toronto, Canada. A graduate of Cornell University and the McMaster University School of Medicine, Dr. Zipursky completed his residency training in psychiatry at the University of Pittsburgh and a postdoctoral research fellowship at Stanford University. Dr. Zipursky's major research interest has been in applying brain imaging techniques to the study of schizophrenia.

S. Charles Schulz, M.D., is Professor and Head of the Department of Psychiatry at the University of Minnesota Medical School in Minneapolis. Dr. Schulz graduated from the University of Southern California before matriculating to the University of California Los Angeles for his medical degree. After completing residency training at UCLA, Dr. Schulz moved to Bethesda, Maryland, where he served as a Clinical Associate at the National Institute of Mental Health. Over the past 20 years, Dr. Schulz has been involved in studying the use of brain imaging and neuropsychology research techniques to treat adolescents suffering from psychosis.

The Early Stages of Schizophrenia is an inspiring book for mental health professionals who work with people who have schizophrenia. . . . As its editors intended, this volume gives hope.—Kelly M. Askins, M.D., Psychiatric Services, 2/1/2003


All-in-all, The Early Stages of Schizophrenia is well worth reading by all of us in the various mental health disciplines, whether in hospitals, clinics, or community programs. . . . I intend to keep the book in my library and consult it frequently.—Jack R. Anderson, M.D., Metapsychology Online Book Reviews, 2/1/2003


Schizophrenia remains one of the most challenging illnesses in all of medicine. This book provides a valuable clinical and research perspective on the early stages of schizophrenia, including its presentation and diagnosis, as well as treatment and research implications. It provides a wealth of information that should be of interest to a wide audience.—John M. Kane, M.D., Vice President for Behavioral Health Services, Chairman, Department of Psychiatry, Hillside Hospital, Glen Oaks, New York

Related Products

Become an APA Member
Join Now